Kaskela Law Firm Announces Investigation of Agilon Health, Inc. (AGL) and Encourages Long-Term AGL Shareholders with Investment Losses to Contact the Firm
Kaskela Law Firm announced an investigation of Agilon Health regarding alleged securities fraud and misleading statements about medical costs between April 2021 and February 2024. The solicitation targets shareholders who purchased shares before May 1, 2023, citing an alleged 85% drop in stock value prior to a 1-for-25 reverse split.
Key figures
- Class period end
- February 27, 2024
- Class period start
- April 15, 2021
- Reverse split ratio
- 1-for-25
- Stock price decline to
- $6.50
- Stock price decline pct
- 85%
- Stock price decline from
- $44.00
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.